EAPI EUROAPI

Combined General Meeting of May 21, 2025 - Availability of preparatory documents

Combined General Meeting of May 21, 2025 - Availability of preparatory documents

 Press Release

   





Paris – April 29, 2025 – EUROAPI’s shareholders are invited to attend the Combined General Meeting to be held on Wednesday May 21, 2025 at 10:30 a.m. (CET) at 15 bis, rue Traversière 75012 Paris.



The notice of meeting was published at the French official legal announcement publication (BALO) on Wednesday April 16, 2025 and the convening notice (avis de convocation) was published in the Actu-juridique.fr, a French journal of legal notice, on April 28, 2025.

The documents and information relating to this General Meeting required under article R. 22-10-23 of the French Commercial Code are posted on the Company’s website (), in the section entitled “Annual General Meeting 2025”.

Registered shareholders can request, within the legal and regulatory deadlines, additional documents, by email at , or by request to the Company's registered office at 15, rue Traversière 75012 Paris.

Shareholders holding their shares in registered form will receive their convening documentation by post, or by email for those who have opted for e-notice. Bearer shareholders should contact their financial intermediary.



Shareholders are invited to regularly consult the section dedicated to the Annual General Meeting on the Company’s website () for the latest information concerning the Annual General Meeting. The Annual General Meeting will be broadcast on live video, unless technical reasons make it impossible or seriously disrupt the broadcast. A replay of the meeting will also be available on the dedicated section of the Company’s website, accessible via the following link: .

About EUROAPI

EUROAPI is focused on reinventing active ingredient solutions to sustainably meet customers’ and patients’ needs around the world. We are a leading player in active pharmaceutical ingredients with approximately 200 products in our portfolio, offering a large span of technologies while developing innovative molecules through our Contract Development and Manufacturing Organization (CDMO) activities.

Taking action for health by enabling access to essential therapies inspires our 3,430 people every day. With strong research and development capabilities and six manufacturing sites, all located in Europe, EUROAPI ensures API manufacturing of the highest quality to supply customers in more than 80 countries. EUROAPI is listed on Euronext Paris; ISIN: FR0014008VX5; ticker: EAPI). Find out more at and follow us on .


Media Relations contact:

Laurence Bollack

Tel.: +33 (0)6 81 86 80 19

























Investor Relations contact:

Sophie Palliez-Capian

Tel.: +33 (0)6 87 89 33 51













Attachment



EN
29/04/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on EUROAPI

 PRESS RELEASE

Combined General Meeting of May 21, 2025 - Availability of preparatory...

Combined General Meeting of May 21, 2025 - Availability of preparatory documents  Press Release    Paris – April 29, 2025 – EUROAPI’s shareholders are invited to attend the Combined General Meeting to be held on Wednesday May 21, 2025 at 10:30 a.m. (CET) at 15 bis, rue Traversière 75012 Paris. The notice of meeting was published at the French official legal announcement publication (BALO) on Wednesday April 16, 2025 and the convening notice (avis de convocation) was published in the Actu-juridique.fr, a French journal of legal notice, on April 28, 2025. The documents and information rela...

 PRESS RELEASE

Assemblée Générale mixte du 21 mai 2025 - Modalités de mise à disposit...

Assemblée Générale mixte du 21 mai 2025 - Modalités de mise à disposition ou de consultation des documents préparatoires   Communiqué de presse   Paris – Le 29 avril 2025 – Les actionnaires d’EUROAPI sont invités à participer à l’Assemblée Générale mixte qui se tiendra le mercredi 21 mai 2025 à 10h30 au 15 bis rue Traversière 75012 Paris. L’avis de réunion a été publié au Bulletin des Annonces Légales Obligatoires (BALO) du mercredi 16 avril 2025, et l’avis de convocation a été publié au journal d’annonces légales Actu-juridique.fr le 28 avril 2025. Les documents et renseignements relat...

 PRESS RELEASE

Availability of the 2024 Universal Registration Document, including th...

Availability of the 2024 Universal Registration Document, including the Annual Financial Report  Press Release    Paris – April 1, 2025 – EUROAPI announces the publication of its 2024 Universal Registration Document in ESEF format, filed with the French Autorité des marchés financiers (AMF) on April 1, 2025. The 2024 Universal Registration Document contains in particular: The annual financial report, including the management report that encompasses namely the Corporate Governance report, the sustainability statement and the company and consolidated statements;The statutory auditors’ repo...

 PRESS RELEASE

Mise à disposition du Document d’Enregistrement Universel 2024, conten...

Mise à disposition du Document d’Enregistrement Universel 2024, contenant le Rapport Financier Annuel   Communiqué de presse   Paris - Le 1er avril 2025 - EUROAPI annonce la publication de son Document d’Enregistrement Universel 2024, au format ESEF, déposé auprès de l’Autorité des marchés financiers (AMF) le 1er avril 2025. Le Document d’Enregistrement Universel 2024 contient notamment : le rapport financier annuel, incluant le Rapport de gestion comprenant notamment les informations en matière de gouvernement d’entreprise et les informations en matière de durabilité, ainsi que les compt...

Ahmed Ben Salem ... (+2)
  • Ahmed Ben Salem
  • Baptiste Lebacq

ResearchPool Subscriptions

Get the most out of your insights

Get in touch